Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, Setsu N, Matsumoto Y, Iwamoto Y, Nakashima Y, Kitabayashi I.

Oncogene. 2019 Oct;38(42):6835-6849. doi: 10.1038/s41388-019-0929-9. Epub 2019 Aug 12.

PMID:
31406254
2.

Clinical results of carbon-ion radiotherapy with separation surgery for primary spine/paraspinal sarcomas.

Matsumoto Y, Matsunobu A, Kawaguchi K, Hayashida M, Iida K, Saiwai H, Okada S, Endo M, Setsu N, Fujiwara T, Baba S, Nomoto S, Nakashima Y.

Int J Clin Oncol. 2019 Nov;24(11):1490-1497. doi: 10.1007/s10147-019-01505-y. Epub 2019 Jul 6.

PMID:
31280398
3.

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.

Dancsok AR, Setsu N, Gao D, Blay JY, Thomas D, Maki RG, Nielsen TO, Demicco EG.

Mod Pathol. 2019 Dec;32(12):1772-1785. doi: 10.1038/s41379-019-0312-y. Epub 2019 Jul 1.

PMID:
31263176
4.

Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.

Endo M, Setsu N, Fujiwara T, Ishii T, Nakagawa M, Yahiro K, Kimura A, Shimada E, Nakashima Y, Matsumoto Y.

Curr Treat Options Oncol. 2019 May 25;20(7):54. doi: 10.1007/s11864-019-0656-z. Review.

PMID:
31129726
5.

Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line.

Yahiro K, Matsumoto Y, Fukushi JI, Kawaguchi KI, Endo M, Setsu N, IIda K, Fukushima S, Nakagawa M, Kimura A, Oda Y, Nakashima Y.

Anal Cell Pathol (Amst). 2018 Jun 21;2018:8987568. doi: 10.1155/2018/8987568. eCollection 2018.

6.

Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line.

Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H, Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T.

In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):528-536. doi: 10.1007/s11626-018-0274-2. Epub 2018 Jun 25.

PMID:
29943355
7.

Clinical Outcome and Prognostic Factors of Malignant Spinal Dumbbell Tumors.

Matsumoto Y, Kawaguchi K, Fukushi JI, Endo M, Setsu N, Iida K, Baba S, Saiwai H, Matsushita A, Hayashida M, Okada S, Nakashima Y.

Spine Surg Relat Res. 2018 Apr 27;2(4):317-323. doi: 10.22603/ssrr.2018-0004. eCollection 2018 Oct 26.

8.

Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.

Fukushima S, Endo M, Matsumoto Y, Fukushi JI, Matsunobu T, Kawaguchi KI, Setsu N, IIda K, Yokoyama N, Nakagawa M, Yahiro K, Oda Y, Iwamoto Y, Nakashima Y.

PLoS One. 2018 Mar 15;13(3):e0194508. doi: 10.1371/journal.pone.0194508. eCollection 2018.

9.

The neurological outcome of radiotherapy versus surgery in patients with metastatic spinal cord compression presenting with myelopathy.

Iida K, Matsumoto Y, Setsu N, Harimaya K, Kawaguchi K, Hayashida M, Okada S, Nakashima Y.

Arch Orthop Trauma Surg. 2018 Jan;138(1):7-12. doi: 10.1007/s00402-017-2817-5. Epub 2017 Oct 14.

10.

Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.

Yamada Y, Kinoshita I, Kenichi K, Yamamoto H, Iwasaki T, Otsuka H, Yoshimoto M, Ishihara S, Toda Y, Kuma Y, Setsu N, Koga Y, Honda Y, Inoue T, Yanai H, Yamashita K, Ito I, Takahashi M, Ohga S, Furue M, Nakashima Y, Oda Y.

Histopathology. 2018 Feb;72(3):460-471. doi: 10.1111/his.13377. Epub 2017 Nov 16.

PMID:
28858396
11.

Metabolic Tumor Volume by 18F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors.

Matsumoto Y, Baba S, Endo M, Setsu N, Iida K, Fukushi JI, Kawaguchi K, Okada S, Bekki H, Isoda T, Kitamura Y, Honda H, Nakashima Y.

Biomed Res Int. 2017;2017:8132676. doi: 10.1155/2017/8132676. Epub 2017 Aug 9.

12.

Evaluation of Risk Factors for Vertebral Compression Fracture after Carbon-Ion Radiotherapy for Primary Spinal and Paraspinal Sarcoma.

Matsumoto Y, Shinoto M, Endo M, Setsu N, Iida K, Fukushi JI, Kawaguchi K, Okada S, Bekki H, Imai R, Kamada T, Shioyama Y, Nakashima Y.

Biomed Res Int. 2017;2017:9467402. doi: 10.1155/2017/9467402. Epub 2017 Jul 26.

13.

Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.

Hiraki-Hotokebuchi Y, Yamada Y, Kohashi K, Yamamoto H, Endo M, Setsu N, Yuki K, Ito T, Iwamoto Y, Furue M, Oda Y.

Hum Pathol. 2017 Sep;67:60-68. doi: 10.1016/j.humpath.2017.07.001. Epub 2017 Jul 13.

PMID:
28711648
14.

Fibroma of Tendon Sheath Presenting Limited Flexion of the Fingers.

Maeda K, Setsu N, Kato Y, Kawai A, Kobayashi E.

Case Rep Orthop. 2017;2017:4129714. doi: 10.1155/2017/4129714. Epub 2017 May 16.

15.

Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.

Fukushima S, Endo M, Matsumoto Y, Fukushi JI, Matsunobu T, Kawaguchi KI, Setsu N, IIda K, Yokoyama N, Nakagawa M, Yahiro K, Oda Y, Iwamoto Y, Nakashima Y.

PLoS One. 2017 May 30;12(5):e0178064. doi: 10.1371/journal.pone.0178064. eCollection 2017. Erratum in: PLoS One. 2018 Mar 15;13(3):e0194508.

16.

Simultaneous reconstruction of the bone and vessels for complex femoral defect.

Miyamoto S, Fujiki M, Setsu N, Kawai A.

World J Surg Oncol. 2016 Nov 18;14(1):291.

17.

Primary Retroperitoneal Myxoid Liposarcomas.

Setsu N, Miyake M, Wakai S, Nakatani F, Kobayashi E, Chuman H, Hiraoka N, Kawai A, Yoshida A.

Am J Surg Pathol. 2016 Sep;40(9):1286-90. doi: 10.1097/PAS.0000000000000657.

18.

[Orthopedic Management of Skeletal Metastases].

Setsu N, Kobayashi E, Kawai A.

Gan To Kagaku Ryoho. 2015 Nov;42(11):1350-4. Japanese.

PMID:
26602394
19.

Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.

Maekawa A, Kohashi K, Setsu N, Kuda M, Iura K, Ishii T, Matsunobu T, Nakatsura T, Iwamoto Y, Oda Y.

Cancer Sci. 2016 Jan;107(1):95-102. doi: 10.1111/cas.12846. Epub 2016 Jan 12.

20.

Pediatric myositis ossificans mimicking osteosarcoma.

Yamaga K, Kobayashi E, Kubota D, Setsu N, Tanaka Y, Minami Y, Tanzawa Y, Nakatani F, Kawai A, Chuman H.

Pediatr Int. 2015 Oct;57(5):996-9. doi: 10.1111/ped.12672. Epub 2015 Aug 19.

PMID:
26508182
21.

Severe hypercalcemia following denosumab treatment in a juvenile patient.

Setsu N, Kobayashi E, Asano N, Yasui N, Kawamoto H, Kawai A, Horiuchi K.

J Bone Miner Metab. 2016 Jan;34(1):118-22. doi: 10.1007/s00774-015-0677-z. Epub 2015 Jun 9.

PMID:
26056018
22.
23.

Osteosclerosis induced by denosumab.

Kobayashi E, Setsu N.

Lancet. 2015 Feb 7;385(9967):539. doi: 10.1016/S0140-6736(14)61338-6. Epub 2014 Oct 28. No abstract available.

PMID:
25465110
24.

Reversible hair depigmentation in a Japanese female treated with pazopanib.

Kobayashi E, Koyama T, Kobayashi K, Setsu N, Kawashima M, Kawai A.

J Dermatol. 2014 Nov;41(11):1021-2. doi: 10.1111/1346-8138.12654. No abstract available.

PMID:
25346306
25.

Chronic expanding hematoma with a significantly high fluorodeoxyglucose uptake on ¹⁸F-fluorodeoxyglucose positron emission tomography, mimicking a malignant soft tissue tumor: a case report.

Nishida Y, Kobayashi E, Kubota D, Setsu N, Ogura K, Tanzawa Y, Nakatani F, Kato Y, Chuman H, Kawai A.

J Med Case Rep. 2014 Oct 21;8:349. doi: 10.1186/1752-1947-8-349.

26.

Activation of the Akt/mammalian target of rapamycin pathway in myxofibrosarcomas.

Takahashi Y, Kohashi K, Yamada Y, Endo M, Setsu N, Ishii T, Yamamoto H, Iwamoto Y, Oda Y.

Hum Pathol. 2014 May;45(5):984-93. doi: 10.1016/j.humpath.2013.12.012. Epub 2014 Jan 8.

PMID:
24746202
27.

Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.

Yamada Y, Kohashi K, Fushimi F, Takahashi Y, Setsu N, Endo M, Yamamoto H, Tokunaga S, Iwamoto Y, Oda Y.

Cancer. 2014 Mar 15;120(6):864-76. doi: 10.1002/cncr.28506. Epub 2013 Dec 18.

28.

Histological analysis suggests an invasion-independent metastatic mechanism in alveolar soft part sarcoma.

Setsu N, Yoshida A, Takahashi F, Chuman H, Kushima R.

Hum Pathol. 2014 Jan;45(1):137-42. doi: 10.1016/j.humpath.2013.07.045.

PMID:
24321522
29.

Conventional spindle cell-type malignant peripheral nerve sheath tumor arising in a sporadic schwannoma.

Endo M, Yamamoto H, Harimaya K, Kohashi K, Ishii T, Setsu N, Iwamoto Y, Oda Y.

Hum Pathol. 2013 Dec;44(12):2845-8. doi: 10.1016/j.humpath.2013.05.021. Epub 2013 Sep 2.

PMID:
24007690
30.

Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.

Setsu N, Kohashi K, Fushimi F, Endo M, Yamamoto H, Takahashi Y, Yamada Y, Ishii T, Yokoyama K, Iwamoto Y, Oda Y.

Cancer. 2013 Oct 1;119(19):3504-13. doi: 10.1002/cncr.28255. Epub 2013 Jul 16.

31.

Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours.

Yamamoto H, Handa M, Tobo T, Setsu N, Fujita K, Oshiro Y, Mihara Y, Yoshikawa Y, Oda Y.

Histopathology. 2013 Aug;63(2):194-207. doi: 10.1111/his.12159. Epub 2013 Jun 13. Review.

PMID:
23763337
32.

Fibrocartilaginous mesenchymoma arising in the pubic bone: a case report.

Takahashi Y, Oda Y, Yamamoto H, Ishii T, Setsu N, Endo M, Matsuda S, Iwamoto Y.

Pathol Int. 2013 Apr;63(4):226-9. doi: 10.1111/pin.12052.

PMID:
23692424
33.

Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma.

Fujiwara-Okada Y, Matsumoto Y, Fukushi J, Setsu N, Matsuura S, Kamura S, Fujiwara T, Iida K, Hatano M, Nabeshima A, Yamada H, Ono M, Oda Y, Iwamoto Y.

Br J Cancer. 2013 Mar 5;108(4):836-47. doi: 10.1038/bjc.2012.579.

34.

Low-grade central osteosarcoma arising from bone infarct.

Endo M, Yoshida T, Yamamoto H, Ishii T, Setsu N, Kohashi K, Matsunobu T, Iwamoto Y, Oda Y.

Hum Pathol. 2013 Jun;44(6):1184-9. doi: 10.1016/j.humpath.2012.11.011. Epub 2013 Jan 31.

PMID:
23375641
35.

Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.

Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, Iida K, Matsumoto Y, Hakozaki M, Aoki M, Iwasaki H, Dobashi Y, Nishiyama K, Iwamoto Y, Oda Y.

Clin Cancer Res. 2013 Jan 15;19(2):450-61. doi: 10.1158/1078-0432.CCR-12-1067. Epub 2012 Dec 3.

36.

Epithelial and cartilaginous differentiation in clear cell chondrosarcoma.

Matsuura S, Ishii T, Endo M, Takahashi Y, Setsu N, Yamamoto H, Tamiya S, Iwamoto Y, Oda Y.

Hum Pathol. 2013 Feb;44(2):237-43. doi: 10.1016/j.humpath.2012.05.012. Epub 2012 Aug 31.

PMID:
22944296
37.

Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.

Setsu N, Kohashi K, Endo M, Yamamoto H, Tamiya S, Takahashi Y, Yamada Y, Ishii T, Matsuda S, Yokoyama R, Iwamoto Y, Oda Y.

Int J Cancer. 2013 Jan 1;132(1):109-15. doi: 10.1002/ijc.27655. Epub 2012 Jun 20.

38.

Inhibin-α and synaptophysin immunoreactivity in synovial sarcoma with granular cell features.

Setsu N, Kohashi K, Endo M, Yamamoto H, Ohishi Y, Sueyoshi K, Iwamoto Y, Tsuneyoshi M, Motoi T, Kumagai A, Oda Y.

Hum Pathol. 2012 Jun;43(6):850-7. doi: 10.1016/j.humpath.2011.07.012. Epub 2011 Nov 4.

PMID:
22055401
39.

The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas.

Setsu N, Yamamoto H, Kohashi K, Endo M, Matsuda S, Yokoyama R, Nishiyama K, Iwamoto Y, Dobashi Y, Oda Y.

Cancer. 2012 Mar 15;118(6):1637-48. doi: 10.1002/cncr.26448. Epub 2011 Aug 11.

40.

Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.

Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M, Kuwano M, Kamura S, Iida K, Okada Y, Koga M, Iwamoto Y.

Am J Pathol. 2011 Sep;179(3):1157-70. doi: 10.1016/j.ajpath.2011.05.034. Epub 2011 Jul 21.

41.

Arginine metabolism in soft tissue sarcoma.

Yan X, Takahara M, Xie L, Gondo C, Setsu N, Oda Y, Takeuchi S, Tu Y, Moroi Y, Furue M.

J Dermatol Sci. 2011 Mar;61(3):211-5. doi: 10.1016/j.jdermsci.2010.12.009. Epub 2011 Jan 13.

PMID:
21292446
42.

Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.

Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.

Clin Cancer Res. 2011 Jun 1;17(11):3771-82. doi: 10.1158/1078-0432.CCR-10-2393. Epub 2011 Jan 24.

43.

Low-grade dedifferentiated liposarcoma of the neck: magnetic resonance imaging and pathological correlation.

Endo M, Oda Y, Harimaya K, Tamiya S, Yamamoto H, Kohashi K, Kurihara S, Setsu N, Matsuura S, Matono H, Matsuda S, Iwamoto Y, Tsuneyoshi M.

J Orthop Sci. 2010 Jan;15(1):148-52. doi: 10.1007/s00776-009-1407-y. Epub 2010 Feb 12. No abstract available.

PMID:
20151266
44.

Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas.

Morizane S, Setsu N, Yamamoto T, Hamada T, Nakanishi G, Asagoe K, Iwatsuki K.

Br J Dermatol. 2009 Jul;161(1):115-20. doi: 10.1111/j.1365-2133.2009.09109.x. Epub 2009 Mar 26.

PMID:
19416265
45.

Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.

Tokuyama Y, Senoh A, Setsu N, Iwatsuki K.

Eur J Dermatol. 2008 Nov-Dec;18(6):725-6. doi: 10.1684/ejd.2008.0535. No abstract available.

PMID:
19049946
46.

A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.

Aochi S, Nakanishi G, Suzuki N, Setsu N, Suzuki D, Aya K, Iwatsuki K.

Br J Dermatol. 2007 Dec;157(6):1265-6. Epub 2007 Oct 4. No abstract available.

PMID:
17916203
47.

Interferon-gamma-induced 15-lipoxygenase-2 expression in normal human epidermal keratinocytes and a pathogenic link to psoriasis vulgaris.

Setsu N, Matsuura H, Hirakawa S, Arata J, Iwatsuki K.

Eur J Dermatol. 2006 Mar-Apr;16(2):141-5.

PMID:
16581564
48.

Koebner phenomenon on skin graft donor site in cutaneous angiosarcoma.

Yamasaki O, Terao K, Asagoe K, Setsu N, Arakawa K, Arata J, Iwatsuki K.

Eur J Dermatol. 2001 Nov-Dec;11(6):584-6.

PMID:
11701415

Supplemental Content

Support Center